AU2007900749A0 - Agents and methods for treatment of cell proliferative diseases and conditions - Google Patents

Agents and methods for treatment of cell proliferative diseases and conditions

Info

Publication number
AU2007900749A0
AU2007900749A0 AU2007900749A AU2007900749A AU2007900749A0 AU 2007900749 A0 AU2007900749 A0 AU 2007900749A0 AU 2007900749 A AU2007900749 A AU 2007900749A AU 2007900749 A AU2007900749 A AU 2007900749A AU 2007900749 A0 AU2007900749 A0 AU 2007900749A0
Authority
AU
Australia
Prior art keywords
agents
treatment
conditions
methods
cell proliferative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007900749A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Research Institute
Newcastle Innovation Ltd
Original Assignee
Childrens Medical Research Institute
Newcastle Innovation Ltd
Filing date
Publication date
Application filed by Childrens Medical Research Institute, Newcastle Innovation Ltd filed Critical Childrens Medical Research Institute
Publication of AU2007900749A0 publication Critical patent/AU2007900749A0/en
Priority to PCT/AU2008/000203 priority Critical patent/WO2008098308A1/en
Abandoned legal-status Critical Current

Links

AU2007900749A 2007-02-15 2007-02-15 Agents and methods for treatment of cell proliferative diseases and conditions Abandoned AU2007900749A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2008/000203 WO2008098308A1 (en) 2007-02-15 2008-02-15 Agents and methods for treatment of cell proliferative diseases and conditions

Publications (1)

Publication Number Publication Date
AU2007900749A0 true AU2007900749A0 (en) 2007-03-01

Family

ID=

Similar Documents

Publication Publication Date Title
EP2315780B8 (en) Compositions and methods of use for therapeutic antibodies
ZA200906210B (en) 3-Imidazolyl-Indoles for the treatment of proliferative diseases
EP2211881A4 (en) Compositions and methods for prevention and treatment of mammalian diseases
HK1201046A1 (en) Methods of treating ophthalmic diseases
EP1977746B8 (en) Methods and compositions for reduction of side effects of therapeutic treatments
HK1154575A1 (en) Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases
IL201650A0 (en) Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
AU2009221838A8 (en) Implants and methods of use
EP2435825B8 (en) Methods of treating diseases
WO2009063492A9 (en) Novel agents for treatment of ailments and dysfunctions
IL195152A (en) Compounds for use in the treatment of cell proliferative disorders
WO2011071995A9 (en) Compounds and methods of treating ocular disorders
HK1245679A1 (en) Methods and compositions for treating dermatological diseases and conditions
ZA201004134B (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
IL204728A0 (en) Methods and compounds for treating retinol-related diseases
HK1149545A1 (en) Compositions and methods for treating ophthalmic diseases
IL213703A0 (en) Compounds and methods for the treatment of pain and other diseases
EP2106260B8 (en) Insulin sensitisers and methods of treatment
EP2142566A4 (en) Methods and compositions for the treatment of proliferative diseases
EP2432358A4 (en) Method and device for treatment of human excrement
AU2009219468A8 (en) Use of black soybean for treating ophthalmic diseases
AU2007900863A0 (en) Agents and methods for treatment of cell proliferative diseases and conditions
AU2007900749A0 (en) Agents and methods for treatment of cell proliferative diseases and conditions
AU2008906584A0 (en) Methods of treatment and agents useful for same
AU2007900455A0 (en) Compounds and Methods of Treatment